Neuromyelitis optica aquaporin-4 antibody negative (Q41177): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Neuromielite óptica (NMO) é uma doença inflamatória desmielinizante do sistema nervoso central caracterizada principalmente por ataques uni ou bilaterais de neurite óptica (NO) e mielite aguda longitudinalmente extensa (> 3 segmentos medulares). Essa forma é soronegativa para anticorpos anti-aquaporina 4. _x000D_ Alguns pacientes podem apresentar positividade para anticorpo contra glicoproteína oligodendrócita da mielina (MOG).
description / endescription / en
 
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system characterised mainly by attacks of uni- or bilateral optic neuritis (ON) and acute longitudinally extensive (> 3 vertebral segments) myelitis. This form is seronegative for aquaporin-4 antibodies. Some patients may be myelin oligodendrocyte glycoprotein (MOG) antibody positive.

Revision as of 07:14, 13 August 2026

Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system characterised mainly by attacks of uni- or bilateral optic neuritis (ON) and acute longitudinally extensive (> 3 vertebral segments) myelitis. This form is seronegative for aquaporin-4 antibodies. Some patients may be myelin oligodendrocyte glycoprotein (MOG) antibody positive.
Language Label Description Also known as
default for all languages
8A43.1
    English
    Neuromyelitis optica aquaporin-4 antibody negative
    Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system characterised mainly by attacks of uni- or bilateral optic neuritis (ON) and acute longitudinally extensive (> 3 vertebral segments) myelitis. This form is seronegative for aquaporin-4 antibodies. Some patients may be myelin oligodendrocyte glycoprotein (MOG) antibody positive.

      Statements